---
title: "CQP released its performance for the first half of the year, with a net profit attributable to the parent company of 282 million yuan, a year-on-year increase of 18.56%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/253783286.md"
description: "CQP released its semi-annual report for 2025, reporting operating revenue of 41.188 billion yuan, a year-on-year increase of 3.54%; net profit attributable to shareholders of the parent company was 282 million yuan, a year-on-year increase of 18.56%; net profit excluding non-recurring gains and losses was 277 million yuan, a year-on-year increase of 26.68%; basic earnings per share were 0.16 yuan"
datetime: "2025-08-20T09:58:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/253783286.md)
  - [en](https://longbridge.com/en/news/253783286.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/253783286.md)
---

# CQP released its performance for the first half of the year, with a net profit attributable to the parent company of 282 million yuan, a year-on-year increase of 18.56%

According to the Zhitong Finance APP, CQP (000950.SZ) released its semi-annual report for 2025. During the reporting period, the company achieved operating revenue of 41.188 billion yuan, a year-on-year increase of 3.54%. The net profit attributable to shareholders of the listed company was 282 million yuan, a year-on-year increase of 18.56%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 277 million yuan, a year-on-year increase of 26.68%. The basic earnings per share were 0.16 yuan

### Related Stocks

- [000950.CN](https://longbridge.com/en/quote/000950.CN.md)

## Related News & Research

- [11:48 ETInventHelp Inventor Develops New Remote Control Finder (TKA-458)](https://longbridge.com/en/news/286941635.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)
- [Palfinger wins Dragados order for seven davit cranes for North Sea HVDC platforms](https://longbridge.com/en/news/287017946.md)
- [Poxel wins Japan patent for imeglimine use in type 2 diabetes patients with renal impairment](https://longbridge.com/en/news/287013341.md)
- [09:15 ETNewport Healthcare's 2025 Outcomes Report Demonstrates Significant Improvements in Teen and Young Adult Mental Health Following Treatment](https://longbridge.com/en/news/286920260.md)